All Stories

  1. Active Brown Adipose Tissue Is Associated With Reduced Arterial Inflammation and Less Atherogenic Circulating Factors in Individuals With Obesity
  2. Real-world effectiveness and antibody responses of BNT162b2 vaccination in long-term care residents: A retrospective case-control study
  3. Sex-specific associations of sedentary behaviour and physical activity with placental and fetal IL-6 in pregnant women with obesity. Impact on neonatal adiposity in the DALI randomised controlled trial
  4. Associations of Diabetes Mellitus Status and Geriatric Nutritional Risk Index with the Gut Microbiota in Nursing-Home Residents
  5. The renin-angiotensin system is activated by short-term, but repressed by long-term growth hormone excess
  6. Physiological Mechanisms in Pregnancy and Their Relevance to the Clinical Management of Perinatal Mental Illness
  7. Cardiovascular effects of metyrapone treatment in patients with mild autonomous cortisol secretion: a secondary analysis
  8. Challenges and knowledge gaps in sex differences in cardio–kidney–metabolic syndrome across the lifespan
  9. Diabetische Nierenerkrankung (Update 2026)
  10. Diagnostik und Therapie des Typ 1 Diabetes mellitus (Update 2026)
  11. Ernährungsempfehlungen für Menschen mit Diabetes (Update 2026)
  12. Geschlechtsspezifische Aspekte bei Prädiabetes und Diabetes mellitus – klinische Empfehlungen (Update 2026)
  13. Management der Hyperglykämie in der Schwangerschaft (Update 2026)
  14. Psychische und neurokognitive Erkrankungen und Diabetes mellitus (Update 2026)
  15. Antihyperglykämische Therapie bei Diabetes mellitus Typ 2 (Update 2026)
  16. Diabetestechnologie (Update 2026)
  17. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge
  18. Challenges in inpatient diabetes care: A single-day snapshot or a shot at the heart of the problem?
  19. Gaps in Glycaemic Monitoring and Underuse of Cardioprotective Glucose-lowering Agents: Challenges of inpatient diabetes care identified by EFIM’s Diabesity Day Survey 2024
  20. Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease
  21. Metabolic effects of metyrapone treatment in patients with mild autonomous cortisol secretion: a prospective proof-of-concept trial
  22. Sex Hormones and Cardiovascular Risk in Type 2 Diabetes: Cohort Study of the Look AHEAD Trial
  23. Determinants of Maximal Oxygen Consumption in Cardiac Rehabilitation Patients: The Role of Sex
  24. Evolocumab in Patients without a Previous Myocardial Infarction or Stroke
  25. N-terminal pro B-type natriuretic peptide increase after bariatric surgery is linked to decreased insulin resistance and is more pronounced in women
  26. Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes
  27. Tracking Chronic Diseases via Mobile Health Applications: Which User Experience Aspects Are Key?
  28. A 10-step guide to standardising patient-reported outcomes data collection in healthcare: insights from the health outcomes observatory (H2O) project on overcoming implementation barriers
  29. Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trial
  30. Myo‐Inositol Deficiency, Structural Brain Changes, and Cerebral Perfusion Alterations in Classic Galactosemia: Preliminary Insights From a Multiparametric MRI Study
  31. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge
  32. Exploring the Influence of Sex and Gender on Cancer: A Comprehensive Analysis
  33. Cluster-Based Immunization Patterns in Diabetes Mellitus: Insights for Personalized Preventive Care
  34. Heterogeneity of effect of Intensive lifestyle intervention on cardiometabolic risk factors by sex hormones in diabetes
  35. 1H and 31P MRS Interleaved With High Time Resolution Reveals Closely Matching Creatine CH₂ and PCr Dynamics During Exercise
  36. Correction to: “Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline”
  37. Association of fetal FTO gene variants with maternal postload glucose levels in pregnancy
  38. Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
  39. Leptin acutely increases hepatic triglyceride secretion in patients with lipodystrophy
  40. Konsensuspapier der Österreichischen Adipositasgesellschaft (ÖAG)
  41. Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline
  42. Relacorilant Improved Blood Pressure and Maintained Other Cardiometabolic Improvements in Long-term Study in Patients With Endogenous Hypercortisolism (Cushing Syndrome)
  43. Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline
  44. 1724-P: Association between Relative Cord Hyperleptinemia and Body Mass Index in Offspring Born to Overweight and Obese Mothers
  45. 178-OR: Sensitivity of Different Screening Approaches for Early Hyperglycemia in Pregnancy
  46. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge
  47. Diabetes und Schwangerschaft
  48. The role of sex differences in cardiovascular, metabolic, and immune functions in health and disease: a review for “Sex Differences in Health Awareness Day”
  49. Finerenone and Clinical Outcomes in CKD and Type 2 Diabetes by Frailty Index
  50. Assessment of fetal hepatic lipid content by magnetic resonance imaging and association of results with clinical maternal and fetal parameters
  51. Bariatric surgery promotes recruitment of brown fat linked to alterations in the gut microbiota
  52. Effectiveness of the Dual GIP/GLP1-Agonist Tirzepatide in 2 Cases of Alström Syndrome, a Rare Obesity Syndrome
  53. Gestational Diabetes Mellitus (GDM), Diagnostics, Therapy and Follow-up Care
  54. A direct effect of the hematocrit on blood glucose: Evidence from hypoxia- and erythropoietin-treated mice
  55. Health Status and Patients’ Satisfaction on the Long Term after Metabolic/Bariatric Surgery
  56. Growth Hormone Promotes Hepatic Triglyceride Export in Humans
  57. Diabetes and Pregnancy
  58. Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes in low-resource settings
  59. Gender-affirming hormone therapy and its impact on myocardial mass and cardiac function: a prospective magnetic resonance cohort study on transgender men and women
  60. Comparing Bioelectrical Impedance Analysis, Air Displacement Plethysmography, and Dual-Energy X-Ray Absorptiometry for Body Composition in Pediatric Obesity
  61. The effects of gender-affirming hormone therapy on myocardial, hepatic, pancreatic lipid content, body fat distribution and other cardiometabolic risk factors: A magnetic resonance-based study in transgender individuals
  62. Vascular strain of the aorta and peripheral arteries in patients with type 1 diabetes mellitus in comparison with healthy controls
  63. Assessing the relationship between sex, gender, and hypertension: A federated analysis of European and Canadian Public Health Surveys
  64. Incidence of Prediabetes and Diabetes in a European Longitudinal General Population Cohort and Its Associated Factors—Results From the Austrian LEAD Study
  65. What all physicians should know about women’s health: a Delphi study
  66. Association Between Glycemia, Glycemic Variability, and Pregnancy Complications in Early GDM
  67. Ethnic Differences in Characteristics of Women Diagnosed With Early Gestational Diabetes: Findings From the TOBOGM Study
  68. Postpartum dysglycaemia after early gestational diabetes: Follow-up of women in the TOBOGM randomised controlled trial
  69. Sex differences in ectopic lipid deposits and cardiac function across a wide range of glycemic control: a secondary analysis
  70. Performance of LDL-C only compared to the Dutch Lipid Clinic Network Score for screening of familial hypercholesterolaemia: the Austrian experience and literature review
  71. Diabetes und Schwangerschaft
  72. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge
  73. Monitoring what matters to people with diabetes: Do we underestimate the importance of behaviour, attitude, and well-being?
  74. Sex, gender, and stroke recovery: Functional limitations and inpatient care needs in Canadian and European survivors
  75. Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT)
  76. Socioeconomic Gender Variables Impact the Association between Hypertension and Chronic Health Issues: Cross-Sectional Study
  77. Effect of treatment for early gestational diabetes mellitus on neonatal respiratory distress: A secondary analysis of the TOBOGM study
  78. Investigating a New Way to Assess Metabolic Risk in Pregnant Females with Prior RYGB Surgery
  79. PCSK9 inhibitors in real life—Cardiometabolic risk management in dyslipidemic patients in Vienna
  80. The Effects of Caloric Restriction and Clinical Psychological Intervention on the Interplay of Gut Microbial Composition and Stress in Women
  81. Sex differences in the diagnostic algorithm of screening for heart failure by symptoms and NT-proBNP in patients with type 2 diabetes
  82. Relationship Between Early-Pregnancy Glycemia and Adverse Outcomes: Findings From the TOBOGM Study
  83. The impact of the SARS-CoV2 pandemic on the prescription of thyroid medication in Austria – A nationwide population-based registry analysis
  84. 202-OR: Prediction of Late Gestational Diabetes Mellitus in Those without Early GDM
  85. 258-OR: The Effect of Early Initiation of Treatment on Glycemia and Pregnancy Outcomes in Women with Early Gestational Diabetes Mellitus
  86. Poor adherence during adolescence is a risk factor for becoming lost-to-follow-up in patients with phenylketonuria
  87. Association of prediabetes with clinical outcomes in patients with chronic coronary syndrome: a post hoc analysis of the ISCHEMIA and ISCHEMIA-CKD trials
  88. Cost-effectiveness of diagnosis and treatment of early gestational diabetes mellitus: economic evaluation of the TOBOGM study, an international multicenter randomized controlled trial
  89. Diabetes und Schwangerschaft
  90. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge
  91. Sex differences of post-Covid patients undergoing outpatient pulmonary rehabilitation
  92. Typ-2-Diabetes: Auch das Geschlecht berücksichtigen
  93. Regression From Early GDM to Normal Glucose Tolerance and Adverse Pregnancy Outcomes in the Treatment of Booking Gestational Diabetes Mellitus Study
  94. Unraveling cradle-to-grave disease trajectories from multilayer comorbidity networks
  95. Association Between Immediate Treatment of Early Gestational Diabetes Mellitus and Breastfeeding Outcomes: Findings From the TOBOGM Study
  96. Role of sex and gender-related variables in development of metabolic syndrome: A prospective cohort study
  97. Female Patients Show a Larger Reduction in Suicidal Ideation in Inpatient Addiction Treatment Than Male Patients: Results of a Single-Center Observational Study
  98. Correlation between skeletal muscle acetylcarnitine and phosphocreatine metabolism during submaximal exercise and recovery: interleaved 1H/31P MRS 7 T study
  99. Profiling endogenous adrenal function during veno-venous ECMO support in COVID-19 ARDS: a descriptive analysis
  100. Gpcpd1–GPC metabolic pathway is dysfunctional in aging and its deficiency severely perturbs glucose metabolism
  101. International consensus on post-transplantation diabetes mellitus
  102. Putting person-centred psychosocial diabetes care into practice: two psychosocial care pathways based on outcome preferences of people with diabetes and healthcare professionals
  103. Linee guida ESC 2023 per il trattamento delle malattie cardiovascolari nei pazienti diabetici
  104. Standardising personalised diabetes care across European health settings: A person‐centred outcome set agreed in a multinational Delphi study
  105. Tracking chronic diseases via mobile health applications: Which user experience aspects are key? (Preprint)
  106. Which diabetes specific patient reported outcomes should be measured in routine care? A systematic review to inform a core outcome set for adults with Type 1 and 2 diabetes mellitus: The European Health Outcomes Observatory (H2O) programme
  107. Sex-Related Disparities in Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Type 2 Diabetes and Heart Failure
  108. Treatment of Gestational Diabetes Mellitus Diagnosed Early in Pregnancy
  109. Diabetes und Schwangerschaft
  110. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge – Kurzfassung der S3-Leitlinie (AWMF-Registernummer: 057-008)
  111. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
  112. Gremlin-1 in pregnancy and postpartum: relation to the fatty liver index, markers of bone health, glucose metabolism and gestational diabetes mellitus status
  113. A comparison of synthetic data generation and federated analysis for enabling international evaluations of cardiovascular health
  114. Diabetes incidence in Austria: The role of famines on diabetes and related NCDs
  115. The relationship between body mass index and sleep in women with risk factors for gestational diabetes mellitus
  116. Treatment of Gestational Diabetes Mellitus Diagnosed Early in Pregnancy
  117. Trends in diabetes incidence in Austria 2013–2017
  118. The Interplay of Adipokines, Body Composition and Glucose Homeostasis in Pregnant Women with a History of RYGB Operation
  119. Age and Sex Determine Electrocardiogram Parameters in the Octodon degus
  120. Excretion of glucose analogue with SGLT2 affinity predicts response effectiveness to sodium glucose transporter 2 inhibitors in patients with type 2 diabetes mellitus
  121. Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism
  122. Correction to: Sex differences in type 2 diabetes
  123. Systematic population-wide ecological analysis of regional variability in disease prevalence
  124. Magnesium in Kidney Function and Disease—Implications for Aging and Sex—A Narrative Review
  125. Sex differences in type 2 diabetes
  126. Sex and gender aspects in diabetes mellitus: Focus on access to health care and cardiovascular outcomes
  127. Simvastatin therapy in higher dosages deteriorates bone quality: Consistent evidence from population-wide patient data and interventional mouse studies
  128. Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open‑label, multinational, randomised, controlled, non-inferiority trial
  129. Diabetes and Pregnancy
  130. Gestational Diabetes Mellitus (GDM), Diagnostics, Therapy and Follow-up Care
  131. Geschlechtsspezifische Aspekte bei Prädiabetes und Diabetes mellitus – klinische Empfehlungen (Update 2023)
  132. Diagnostik und Therapie des Typ 1 Diabetes mellitus (Update 2023)
  133. Diabetestechnologie (Update 2023)
  134. Antihyperglykämische Therapie bei Diabetes mellitus Typ 2 (Update 2023)
  135. Gravidität bei vorbestehendem Diabetes (Update 2023)
  136. Diabetische Nierenerkrankung (Update 2023)
  137. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge
  138. Gestationsdiabetes (GDM) (Update 2023)
  139. Injektionstherapie (GLP1-Rezeptor Agonisten und Insulin) bei Typ 2 Diabetes mellitus (Update 2023)
  140. Psychische und neurokognitive Erkrankungen und Diabetes mellitus (Update 2023)
  141. Ernährungsempfehlungen für Menschen mit Diabetes (Update 2023)
  142. Diabetes und Schwangerschaft
  143. Criteria for prediabetes and posttransplant diabetes mellitus after kidney transplantation: A 2-year diagnostic accuracy study of participants from a randomized controlled trial
  144. Diabetes mellitus is associated with a higher relative risk for venous thromboembolism in females than in males
  145. The Timing of Pregnancies After Bariatric Surgery has No Impact on Children’s Health—a Nationwide Population-based Registry Analysis
  146. Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study
  147. Leptin increases hepatic triglyceride export via a vagal mechanism in humans
  148. Sex and Gender Impact Mental and Emotional Well-Being During COVID-19 Pandemic: A European Countries Experience
  149. Effects of gender-affirming hormone therapy on cardiovascular risk factors focusing on glucose metabolism in an Austrian transgender cohort
  150. Diabetes und Schwangerschaft
  151. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge – Kurzfassung der S3-Leitlinie (AWMF-Registernummer: 057-008)
  152. Need for improving immunization status and preventive care in diabetes mellitus patients
  153. Vitamin D3 Supplementation in Overweight/Obese Pregnant Women: No Effects on the Maternal or Fetal Lipid Profile and Body Fat Distribution—A Secondary Analysis of the Multicentric, Randomized, Controlled Vitamin D and Lifestyle for Gestational Diabetes...
  154. The Weak Relationship between Vitamin D Compounds and Glucose Homeostasis Measures in Pregnant Women with Obesity: An Exploratory Sub-Analysis of the DALI Study
  155. Gender dimension in cardio-pulmonary continuum
  156. Stress-testing the resilience of the Austrian healthcare system using agent-based simulation
  157. Nahrungsergänzungsmittel und die Schilddrüse – ein Update zur Supplementierung von Mikronährstoffen
  158. Biomarkers Predictive for In-Hospital Mortality in Patients with Diabetes Mellitus and Prediabetes Hospitalized for COVID-19 in Austria: An Analysis of COVID-19 in Diabetes Registry
  159. Awareness of sex and gender dimensions among physicians: the European federation of internal medicine assessment of gender differences in Europe (EFIM-IMAGINE) survey
  160. HbA1c and Glucose Management Indicator Discordance Associated with Obesity and Type 2 Diabetes in Intermittent Scanning Glucose Monitoring System
  161. Evaluation of a bariatric monitoring pass for primary care physicians
  162. Angiotensin‐converting enzyme 2 and transmembrane protease serine 2 in female and male patients with end‐stage kidney disease
  163. Authors’ Reply to: Using Caution When Interpreting Gender-Based Relative Risk. Comment on “The Effect of Cardiovascular Comorbidities on Women Compared to Men: Longitudinal Retrospective Analysis”
  164. Sex Differences in Clinical Characteristics and Outcomes of Patients with SARS-CoV-2-Infection Admitted to Intensive Care Units in Austria
  165. Neurotensin and Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention
  166. Deciphering metformin action in obese mice: A critical re-evaluation of established protocols
  167. Cardiovascular health through a sex and gender lens in six South Asian countries: Findings from the WHO STEPS surveillance
  168. Unraveling the Factors Determining Development of Type 2 Diabetes in Women With a History of Gestational Diabetes Mellitus Through Machine-Learning Techniques
  169. Authors’ Reply to: Using Caution When Interpreting Gender-Based Relative Risk. Comment on “The Effect of Cardiovascular Comorbidities on Women Compared to Men: Longitudinal Retrospective Analysis” (Preprint)
  170. Sex and Gender Influence on Cardiovascular Health in Sub-Saharan Africa: Findings from Ghana, Gambia, Mali, Guinea, and Botswana
  171. Diabetes und Schwangerschaft
  172. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge
  173. Glypican-4 in pregnancy and its relation to glucose metabolism, insulin resistance and gestational diabetes mellitus status
  174. Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial
  175. COVID-19 In-Hospital Mortality in People with Diabetes Is Driven by Comorbidities and Age—Propensity Score-Matched Analysis of Austrian National Public Health Institute Data
  176. Adipocyte STAT5 deficiency does not affect blood glucose homeostasis in obese mice
  177. Women With Cerebral Infarction Feature Worse Clinical Profiles at Admission but Comparable Success to Men During Long-Term Inpatient Neurorehabilitation
  178. Sex-Specific Differences in Mortality of Patients with a History of Bariatric Surgery: a Nation-Wide Population-Based Study
  179. Does diabetes mellitus mitigate the gender gap in COVID-19 mortality?
  180. The unexplored role of sedentary time and physical activity in glucose and lipid metabolism‐related placental mRNAs in pregnant women who are obese: the DALI lifestyle randomised controlled trial
  181. Model-Based Assessment of Hepatic and Extrahepatic Insulin Clearance from Short Insulin-Modified IVGTT in Women with a History of Gestational Diabetes
  182. Short Term Caloric Restriction and Biofeedback Enhance Psychological Wellbeing and Reduce Overweight in Healthy Women
  183. Glucose intolerance in aging is mediated by the Gpcpd1-GPC metabolic axis
  184. Active Brown Adipose Tissue is Associated With a Healthier Metabolic Phenotype in Obesity
  185. Sex-Specific Effects of Vitamin D Status on the Metabolic Profile in Prediabetic Subjects
  186. The Effect of Cardiovascular Comorbidities on Women Compared to Men: Longitudinal Retrospective Analysis
  187. Characterization of endogenous bile acid composition in individuals with cold-activated brown adipose tissue
  188. Diabetes und Schwangerschaft
  189. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge – Kurzfassung der S3-Leitlinie (AWMF-Registernummer: 057-008)
  190. Insulin as Monotherapy and in Combination with Other Glucose-Lowering Drugs Is Related to Increased Risk of Diagnosis of Pneumonia: A Longitudinal Assessment over Two Years
  191. Sex, rurality and socioeconomical status in Spanish centennial population (2017)
  192. Role of GDF-15, YKL-40 and MMP 9 in patients with end-stage kidney disease: focus on sex-specific associations with vascular outcomes and all-cause mortality
  193. Sex differences in brown adipose tissue activity and cold-induced thermogenesis
  194. Determinants of perceived health and unmet healthcare needs in universal healthcare systems with high gender equality
  195. Increase in testosterone levels is related to a lower risk of conversion of prediabetes to manifest diabetes in prediabetic males
  196. Data-driven identification of complex disease phenotypes
  197. Project “Backtoclinic I”: An overview on the state of care of adult PKU patients in Austria
  198. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge
  199. Diabetes und Schwangerschaft
  200. Combined hormonal contraceptives are associated with minor changes in composition and diversity in gut microbiota of healthy women
  201. Diagnostic Role of PET/CT Tracers in the Detection and Localization of Tumours Responsible for Ectopic Cushing’s Syndrome
  202. Risk of Typical Diabetes-Associated Complications in Different Clusters of Diabetic Patients: Analysis of Nine Risk Factors
  203. Diabetes Mellitus is Associated with a Higher Relative Risk for Parkinson’s Disease in Women than in Men
  204. Comparison of Bioelectrical Impedance-Based Methods on Body Composition in Young Patients with Obesity
  205. Iron Deficiency – Not Only a Premenopausal Topic After Bariatric Surgery?
  206. Sex-Related Differences in Drugs with Anti-Inflammatory Properties
  207. Sex- and Gender-Based Pharmacological Response to Drugs
  208. Identification and inclusion of gender factors in retrospective cohort studies: the GOING-FWD framework
  209. Gestational Diabetes Mellitus (GDM), Diagnostics, Therapy and Follow-up Care
  210. The Effect of Cardiovascular Comorbidities on Women Compared to Men: Longitudinal Retrospective Analysis (Preprint)
  211. Major Depressive Disorder (MDD) and Antidepressant Medication Are Overrepresented in High-Dose Statin Treatment
  212. Combined exenatide and dapagliflozin has no additive effects on reduction of hepatocellular lipids despite better glycaemic control in patients with t...
  213. Acute and Life-threatening Complications in Cushing Syndrome: Prevalence, Predictors, and Mortality
  214. Biological and Psychological Stress Correlates Are Linked to Glucose Metabolism, Obesity, and Gender Roles in Women
  215. Diabetes and Pregnancy
  216. Decompression of Multimorbidity Along the Disease Trajectories of Diabetes Mellitus Patients
  217. Oral Contraceptive Intake and Iodine Status in Young Women
  218. Methods for prospectively incorporating gender into health sciences research
  219. RANK links thymic regulatory T cells to fetal loss and gestational diabetes in pregnancy
  220. Gluconeogenesis, But Not Glycogenolysis, Contributes to the Increase in Endogenous Glucose Production by SGLT-2 Inhibition
  221. Precision Medicine for the Management of Therapy Refractory Colorectal Cancer
  222. COVID‐19 fatality prediction in people with diabetes and prediabetes using a simple score upon hospital admission
  223. Intact vitamin A transport is critical for cold-mediated adipose tissue browning and thermogenesis
  224. Outcome of Targeted Therapy Recommendations for Metastatic and Recurrent Head and Neck Cancers
  225. HbA1c during early pregnancy reflects beta-cell dysfunction in women developing GDM
  226. Targeted Therapy Recommendations for Therapy Refractory Solid Tumors—Data from the Real-World Precision Medicine Platform MONDTI
  227. CTRP-1 levels are related to insulin resistance in pregnancy and gestational diabetes mellitus
  228. Metabolic phenotypes of early gestational diabetes mellitus and their association with adverse pregnancy outcomes
  229. Do Women with Diabetes Need More Intensive Action for Cardiovascular Reduction than Men with Diabetes?
  230. Performance of early pregnancy HbA1c for predicting gestational diabetes mellitus and adverse pregnancy outcomes in obese European women
  231. Diabetes und Schwangerschaft
  232. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge – Praxisempfehlung – Kurzfassung der S3-Leitlinie (AWMF-Registernummer: 057-008)
  233. Measurements of Plasma-Free Metanephrines by Immunoassay Versus Urinary Metanephrines and Catecholamines by Liquid Chromatography with Amperometric Detection for the Diagnosis of Pheochromocytoma/Paraganglioma
  234. Effects of Thyroid Function on Phosphodiester Concentrations in Skeletal Muscle and Liver: An In Vivo NMRS Study
  235. How Specialist Aftercare Impacts Long-Term Readmission Risks in Elderly Patients With Metabolic, Cardiac, and Chronic Obstructive Pulmonary Diseases: Cohort Study Using Administrative Data
  236. Metabolic syndrome and visceral adipose tissue (VAT) are associated with obstructive and restrictive lung function impairment
  237. The influence of sex and gender domains on COVID-19 cases and mortality
  238. Diabetes mellitus is associated with a higher risk for major depressive disorder in women than in men
  239. Sex-specific trends in smoking prevalence over seven years in different Austrian populations: results of a time-series cross-sectional analysis
  240. Betatrophin is downregulated in pregnant women with a history of RYGB operation and a high risk of postprandial hypoglycaemia
  241. Muscle‐Specific Relation of Acetylcarnitine and Intramyocellular Lipids to Chronic Hyperglycemia: A Pilot 3‐T 1H MRS Study
  242. Secretagogin is Related to Insulin Secretion but Unrelated to Gestational Diabetes Mellitus Status in Pregnancy
  243. Less sedentary time is associated with a more favourable glucose-insulin axis in obese pregnant women—a secondary analysis of the DALI study
  244. Positioning sulphonylureas in a modern treatment algorithm for patients with type 2 diabetes: Expert opinion from a European consensus panel
  245. Insulin clearance is altered in women with a history of gestational diabetes progressing to type 2 diabetes
  246. Pre-operative Obesity-Associated Hyperandrogenemia in Women and Hypogonadism in Men Have No Impact on Weight Loss Following Bariatric Surgery
  247. Micro- and macrovascular function in patients suffering from primary adrenal insufficiency: a cross-sectional case–control study
  248. Psychopharmacological Medication Has No Influence on Vitamin Status After Bariatric Surgery in Long-term Follow-up
  249. Diabetes und Schwangerschaft
  250. Versorgung von Kindern und Jugendlichen mit Diabetes an Österreichs Schulen
  251. Sublingual microvasculature in diabetic patients
  252. The importance of maternal insulin resistance throughout pregnancy on neonatal adiposity
  253. The Presence of Active Brown Adipose Tissue Determines Cold-Induced Energy Expenditure and Oxylipin Profiles in Humans
  254. Identification and Potential Clinical Utility of the MTNR1B rs10830963 Core Gene Variant Associated to Endophenotypes in Gestational Diabetes Mellitus
  255. Assessing the quality of life among patients with diabetes in Austria and the correlation between glycemic control and the quality of life
  256. Increased ATP synthesis might counteract hepatic lipid accumulation in acromegaly
  257. High-risk multimorbidity patterns on the road to cardiovascular mortality
  258. Temporal relationships between maternal metabolic parameters with neonatal adiposity in women with obesity differ by neonatal sex: Secondary analysis of the DALI study
  259. Response evaluation of SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus using 18F-FDG PET/MRI
  260. The DALI vitamin D randomized controlled trial for gestational diabetes mellitus prevention: No major benefit shown besides vitamin D sufficiency
  261. Marked differences in prediabetes‐ and diabetes‐associated comorbidities between men and women—Epidemiological results from a general population‐based cohort aged 6‐80 years—The LEAD (Lung, hEart, sociAl, boDy) study
  262. Cold-mediated regulation of systemic retinol transport controls adipose tissue browning
  263. How Specialist Aftercare Impacts Long-Term Readmission Risks in Elderly Patients With Metabolic, Cardiac, and Chronic Obstructive Pulmonary Diseases: Cohort Study Using Administrative Data (Preprint)
  264. Metabolic effects of a prolonged, very-high-dose dietary fructose challenge in healthy subjects
  265. Comments on: A functional polymorphism rs10830963 in melatonin receptor 1B associated with the risk of gestational diabetes mellitus
  266. Bariatric Surgery Impacts Levels of Serum Lipids during Pregnancy
  267. Former gestational diabetes: Mathematical modeling of intravenous glucose tolerance test for the assessment of insulin clearance and its determinants
  268. Glucose Effectiveness from Short Insulin-Modified IVGTT and Its Application to the Study of Women with Previous Gestational Diabetes Mellitus
  269. Sex-Related Differences in Pharmacokinetics and Pharmacodynamics of Frequently Prescribed Drugs: A Review of the Literature
  270. Relationship between psychological stress and metabolism in morbidly obese individuals
  271. Response to: ‘Association between osteoporosis and statin therapy: the story continues’ by Burden and Weiler
  272. Versorgung von Kindern und Jugendlichen mit Diabetes an Österreichs Schulen
  273. The Effects of Lifestyle and/or Vitamin D Supplementation Interventions on Pregnancy Outcomes: What Have We Learned from the DALI Studies?
  274. Assessing the health-related quality of life in type 2 diabetes patients treated with insulin and oral antidiabetic agents
  275. Evidence that the multiflorine‐derived substituted quinazolidine 55P0251 augments insulin secretion and lowers blood glucose via antagonism at α 2 ‐adrenoceptors in mice
  276. Österreichischer Blutdruckkonsens 2019
  277. Response to: ‘The association between osteoporosis and statins therapy’ by Lai
  278. Diabetes und Schwangerschaft
  279. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge – Praxisempfehlung – Kurzfassung der S3-Leitlinie (AWMF-Registernummer: 057-008)
  280. Diagnosis of osteoporosis in statin-treated patients is dose-dependent
  281. Insulin Clearance in Women with a History of Gestational Diabetes Assessed by Mathematical Model Analyses of Intravenous Glucose Tolerance Test
  282. Model-Based Assessment of Sex Differences in Glucose Effectiveness and Its Components
  283. Influence of Genotype and Hyperandrogenism on Sexual Function in Women With Congenital Adrenal Hyperplasia
  284. Identifying a disease-specific renin–angiotensin–aldosterone system fingerprint in patients with primary adrenal insufficiency
  285. Nutritional Lifestyle Intervention in Obese Pregnant Women, Including Lower Carbohydrate Intake, Is Associated With Increased Maternal Free Fatty Acids, 3-β-Hydroxybutyrate, and Fasting Glucose Concentrations: A Secondary Factorial Analysis of the Euro...
  286. Plasma renin levels are associated with cardiac function in primary adrenal insufficiency
  287. Diabetes und Schwangerschaft
  288. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge
  289. Diagnose und Management der Osteoporose bei Diabetes mellitus (Update 2019)
  290. Insulinpumpentherapie bei Kindern, Jugendlichen und Erwachsenen (Update 2019)
  291. Psychische Erkrankungen und Diabetes mellitus (Update 2019)
  292. Antihyperglykämische Therapie bei Diabetes mellitus Typ 2 (Update 2019)
  293. Gravidität bei vorbestehendem Diabetes (Update 2019)
  294. Diabetische Nierenerkrankung (Update 2019)
  295. Diagnostik und Therapie des Typ 1 Diabetes mellitus (Update 2019)
  296. Gestationsdiabetes (GDM) (Update 2019)
  297. Insulintherapie bei Typ 2 Diabetes mellitus (Update 2019)
  298. Ernährungsempfehlungen bei Diabetes mellitus (Update 2019)
  299. Geschlechtsspezifische Aspekte bei Prädiabetes und Diabetes mellitus – klinische Empfehlungen (Update 2019)
  300. Zusammenfassung der Überarbeitungen 2019
  301. Glucose effectiveness and its components in relation to body mass index
  302. A reduction in sedentary behaviour in obese women during pregnancy reduces neonatal adiposity: the DALI randomised controlled trial
  303. A Sex-Specific Analysis of the Predictive Value of Troponin I and T in Patients With and Without Diabetes Mellitus After Successful Coronary Intervention
  304. Markedly Delayed Insulin Secretion and a High Rate of Undetected Overt Diabetes Characterize Glucose Metabolism in Adult Patients with Cystic Fibrosis After Lung Transplantation
  305. Glucagon-like peptide 1 (GLP-1) drives postprandial hyperinsulinemic hypoglycemia in pregnant women with a history of Roux-en-Y gastric bypass operation
  306. Mediators of Lifestyle Behaviour Changes in Obese Pregnant Women. Secondary Analyses from the DALI Lifestyle Randomised Controlled Trial
  307. Decreased beta-cell function in breastfeeding obese and non-obese women: A prospective observational study
  308. Gestational Diabetes Mellitus (GDM) – Diagnosis, Treatment and Follow-Up. Guideline of the DDG and DGGG (S3 Level, AWMF Registry Number 057/008, February 2018)
  309. Sex- and age-related differences of metabolic parameters in impaired glucose metabolism and type 2 diabetes compared to normal glucose tolerance
  310. The MTNR1B rs10830963 Variant in Interaction with Pre-Pregnancy BMI is a Pharmacogenetic Marker for the Initiation of Antenatal Insulin Therapy in Gestational Diabetes Mellitus
  311. Sex-specific analysis of haemodialysis prevalence, practices and mortality over time: the Austrian Dialysis Registry from 1965 to 2014
  312. The wave of sweetness and obesity continues
  313. Association between Gestational Weight Gain, Gestational Diabetes Risk, and Obstetric Outcomes: A Randomized Controlled Trial Post Hoc Analysis
  314. Diabetes und Schwangerschaft
  315. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge
  316. Pericardial Fat Relates to Disturbances of Glucose Metabolism in Women with the Polycystic Ovary Syndrome, but Not in Healthy Control Subjects
  317. Job-related meaningfulness moderates the association between over-commitment and emotional exhaustion in nurses
  318. Adiponectin and Leptin at Early Pregnancy: Association to Actual Glucose Disposal and Risk for GDM—A Prospective Cohort Study
  319. Risk factors for hyperglycemia in pregnancy in the DALI study differ by period of pregnancy and OGTT time point
  320. Needle beats pill in gestational diabetes mellitus
  321. Assessment of glucose effectiveness from short IVGTT in individuals with different degrees of glucose tolerance
  322. Re: Vitamin D and gestational diabetes mellitus: a systematic review based on data free of Hawthorne effect
  323. Management of Pregnant Women after Bariatric Surgery
  324. Sex and Gender Differences in Prevention of Type 2 Diabetes
  325. Cost-effectiveness of healthy eating and/or physical activity promotion in pregnant women at increased risk of gestational diabetes mellitus: economic evaluation alongside the DALI study, a European multicenter randomized controlled trial
  326. Accuracy, User Acceptability, and Safety Evaluation for the FreeStyle Libre Flash Glucose Monitoring System When Used by Pregnant Women with Diabetes
  327. Diabetes in pregnancy: a new decade of challenges ahead
  328. Combined Metabolomic Analysis of Plasma and Urine Reveals AHBA, Tryptophan and Serotonin Metabolism as Potential Risk Factors in Gestational Diabetes Mellitus (GDM)
  329. Correlates of poor mental health in early pregnancy in obese European women
  330. Diabetes und Schwangerschaft
  331. Gestationsdiabetes mellitus (GDM) –Diagnostik, Therapie und Nachsorge , ,
  332. Assessment of glucose regulation in pregnancy after gastric bypass surgery
  333. Gliptin therapy reduces hepatic and myocardial fat in type 2 diabetic patients
  334. Is a motivational interviewing based lifestyle intervention for obese pregnant women across Europe implemented as planned? Process evaluation of the DALI study
  335. Sex and gender differences in therapy of type 2 diabetes
  336. Usefulness of Elevated Levels of Growth Differentiation Factor-15 to Classify Patients With Acute Coronary Syndrome Having Percutaneous Coronary Intervention Who Would Benefit from High-Dose Statin Therapy
  337. Gut microbiota dysbiosis associated with glucose metabolism disorders and the metabolic syndrome in older adults
  338. Influence of gender, working field and psychosocial factors on the vulnerability for burnout in mental hospital staff: results of an Austrian cross-sectional study
  339. Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes
  340. Epidemiology of gestational diabetes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in Europe
  341. Mann oder Frau: Ist das bei Diabetes relevant?
  342. The Fatty Liver Index (FLI) Relates to Diabetes-Specific Parameters and an Adverse Lipid Profile in a Cohort of Nondiabetic, Dyslipidemic Patients
  343. Similarities in trabecular hypertrophy with site-specific differences in cortical morphology between men and women with type 2 diabetes mellitus
  344. Diabetes und Schwangerschaft
  345. Impact of Diabetes Mellitus on Ischemic Events in Men and Women After Percutaneous Coronary Intervention
  346. Switch to Combined GLP1 Receptor Agonist Lixisenatide with Basal Insulin Glargine in Poorly Controlled T2DM Patients with Premixed Insulin Therapy: A Clinical Observation and Pilot Study in Nine Patients
  347. Microvascular function in women with former gestational diabetes: A cohort study
  348. Association Study with 77 SNPs Confirms the Robust Role for the rs10830963/G of MTNR1B Variant and Identifies Two Novel Associations in Gestational Diabetes Mellitus Development
  349. Type 2 Diabetes and Cardiovascular Risk in Women 2016
  350. Effect of physical activity and/or healthy eating on GDM risk: The DALI Lifestyle Study
  351. Increased Proportion of Hematopoietic Stem and Progenitor Cell Population in Cord Blood of Neonates Born to Mothers with Gestational Diabetes Mellitus
  352. Better insight into gender-specific diabetes self-management for more effective diabetes services
  353. Use of statins offsets insulin-related cancer risk
  354. Gestationsdiabetes mellitus (GDM) –Diagnostik, Therapie und Nachsorge ,
  355. Diabetes und Schwangerschaft
  356. Altered glucose profiles and risk for hypoglycaemia during oral glucose tolerance testing in pregnancies after gastric bypass surgery
  357. Wie Gender in die Diabetes-Selbstmanagement-Applikation kommt – ein vielversprechender Weg
  358. Diabetes und Schwangerschaft
  359. To Assess the Association between Glucose Metabolism and Ectopic Lipid Content in Different Clinical Classifications of PCOS
  360. The impact of preconceptional obesity on trajectories of maternal lipids during gestation
  361. Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
  362. IADPSG and WHO 2013 Gestational Diabetes Mellitus Criteria Identify Obese Women With Marked Insulin Resistance in Early Pregnancy: Table 1
  363. Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study
  364. Migration und Diabetes
  365. Psychische Erkrankungen und Diabetes mellitus
  366. Insulintherapie bei Diabetes mellitus
  367. Geschlechtsspezifische Aspekte für die klinische Praxis bei Prädiabetes und Diabetes mellitus
  368. Gestationsdiabetes (GDM)
  369. Gravidität bei vorbestehendem Diabetes für die Leitlinien für die Praxis (AG Diabetes und Schwangerschaft der ÖDG)
  370. Insulinpumpentherapie bei Kindern, Jugendlichen und Erwachsenen
  371. Diabetische Nierenerkrankung – Update 2016
  372. Antihyperglykämische Therapie bei Diabetes mellitus Typ 2
  373. Initial evidence for the link between activities and health: Associations between a balance of activities, functioning and serum levels of cytokines and C-reactive protein
  374. Brennpunkt Adipositas: what gender has to do with …!
  375. Sexualität bei Übergewicht und Adipositas
  376. Clinical and metabolic characteristics of treated hyperlipidemic patients additionally affected by subclinical hyperglycemia
  377. Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients
  378. Diabetes mellitus und Schwangerschaft
  379. The Cross-Link between Adipokines, Insulin Resistance and Obesity in Offspring of Diabetic Pregnancies
  380. Cardiometabolic Risk in Hyperlipidemic Men and Women
  381. Beliefs, Barriers, and Preferences of European Overweight Women to Adopt a Healthier Lifestyle in Pregnancy to Minimize Risk of Developing Gestational Diabetes Mellitus: An Explorative Study
  382. Gender Obesity Report – Einfluss von Adipositas auf Reproduktion und Schwangerschaft
  383. Human insulin dynamics in women: a physiologically based model
  384. Gender Awareness bei Medizinstudierenden der Medizinischen Universität Wien. Eine empirische Analyse von Geschlechtersensibilität und Geschlechterstereotypisierungen
  385. Application of Penalized Regression Techniques in Modelling Insulin Sensitivity by Correlated Metabolic Parameters
  386. Gender and heart disease
  387. Circulating Betatrophin Is Strongly Increased in Pregnancy and Gestational Diabetes Mellitus
  388. Potential of a Sports Club–Based Exercise Program for Improving Physical Activity in Type 2 Diabetes Mellitus
  389. Lactation and appetite-regulating hormones: increased maternal plasma peptide YY concentrations 3–6 months postpartum
  390. Physical activity, depressed mood and pregnancy worries in European obese pregnant women: results from the DALI study
  391. Results From a European Multicenter Randomized Trial of Physical Activity and/or Healthy Eating to Reduce the Risk of Gestational Diabetes Mellitus: The DALI Lifestyle Pilot
  392. Sex-related differences in baseline characteristics, management and outcome in patients with acute coronary syndrome without ST-segment elevation
  393. Diabetes in pregnancy outcomes: A systematic review and proposed codification of definitions
  394. To explain the variation of OGTT dynamics by biological mechanisms: a novel approach based on principal components analysis in women with history of GDM
  395. Quantification of Diabetes Comorbidity Risks across Life Using Nation-Wide Big Claims Data
  396. Gender-based differences in glycaemic control and hypoglycaemia prevalence in patients with type 2 diabetes: results from patient-level pooled data of six randomized controlled trials
  397. Pathophysiological Characteristics and Effects of Obesity in Women With Early and Late Manifestation of Gestational Diabetes Diagnosed by the International Association of Diabetes and Pregnancy Study Groups Criteria
  398. Contrast induced acute kidney injury in acute coronary syndrome patients: A single centre experience
  399. Do patient-reported outcome measures cover personal factors important to people with rheumatoid arthritis? A mixed methods design using the International Classification of Functioning, Disability and Health as frame of reference
  400. Cord serum dipeptidyl-peptidase 4 activity in gestational diabetes
  401. Diabetes und Schwangerschaft
  402. Diabetes mellitus und Schwangerschaft
  403. Type 2 Diabetes and Cardiovascular Risk in Women
  404. Hidden Metabolic Disturbances in Women with Normal Glucose Tolerance Five Years after Gestational Diabetes
  405. Definitions of occupational balance and their coverage by instruments
  406. Iodine deficiency in pregnant women in Austria
  407. Sex-specific differences in diabetes prevention: a systematic review and meta-analysis
  408. No Evidence of Ectopic Lipid Accumulation in the Pathophysiology of the Acromegalic Cardiomyopathy
  409. CN-06 * IS HYPOPITUITARISM CLINICALLY RELEVANT IN GLIOMA PATIENTS? - A CROSS-SELECTIONAL TRIAL IN PATIENTS WITH HIGH-GRADE GLIOMAS
  410. Sex-Specific Differences in Hemodialysis Prevalence and Practices and the Male-to-Female Mortality Rate: The Dialysis Outcomes and Practice Patterns Study (DOPPS)
  411. Biomarkers of endothelial dysfunction in relation to impaired carbohydrate metabolism following pregnancy with gestational diabetes mellitus
  412. Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions
  413. Gendermedizin
  414. Gestational Diabetes Mellitus (GDM) Diagnosis, Therapy and Follow-Up Care
  415. Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial
  416. Is early postpartum HbA1c an appropriate risk predictor after pregnancy with gestational diabetes mellitus?
  417. Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals
  418. Hepatic Rather Than Cardiac Steatosis Relates to Glucose Intolerance in Women with Prior Gestational Diabetes
  419. Predicting the Metabolic Condition After Gestational Diabetes Mellitus from Oral Glucose Tolerance Test Curves Shape
  420. Diabetes in Hyperparathyroidism
  421. Gestational diabetes mellitus and cardiovascular risk after pregnancy
  422. Effect of Fetal and Infant Malnutrition on Metabolism in Older Age
  423. Health determining concepts important to people with Crohn's disease and their coverage by patient-reported outcomes of health and wellbeing
  424. Typ-1-Diabetes
  425. Development of a new occupational balance-questionnaire: incorporating the perspectives of patients and healthy people in the design of a self-reported occupational balance outcome instrument
  426. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma
  427. Diabetologie kompakt
  428. Diabetes und Schwangerschaft
  429. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer
  430. Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer
  431. Lower Fasting Muscle Mitochondrial Activity Relates to Hepatic Steatosis in Humans
  432. Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy
  433. DALI: Vitamin D and lifestyle intervention for gestational diabetes mellitus (GDM) prevention: an European multicentre, randomised trial – study protocol
  434. Analysis of Intravenous Glucose Tolerance Test Data Using Parametric and Nonparametric Modeling: Application to a Population at Risk for Diabetes
  435. Geschlechtsspezifische Unterschiede der Endokrinologie im Alter
  436. Reply to Klitz and Niklasson: Can viral infections explain the cross-sectional Austrian diabetes data?
  437. Quantification of excess risk for diabetes for those born in times of hunger, in an entire population of a nation, across a century
  438. Relationship of pentraxin 3 with insulin sensitivity in gestational diabetes
  439. Nur „der kleine Unterschied“?
  440. Concentration of Free Amino Acids in Human Milk of Women with Gestational Diabetes Mellitus and Healthy Women
  441. Estimating the risk after gestational diabetes mellitus: can we improve the information from the postpartum OGTT?
  442. Lipoprotein(a) is not related to markers of insulin resistance in pregnancy
  443. Sex-specific-differences in cardiometabolic risk in type 1 diabetes: a cross-sectional study
  444. The impact of recurrent gestational diabetes on maternal metabolic and cardiovascular risk factors
  445. Migration und Diabetes
  446. Positionspapier: Psychische Erkrankungen und Diabetes mellitus
  447. Insulintherapie bei Diabetes mellitus
  448. Geschlechtsspezifische Aspekte für die klinische Praxis bei Prädiabetes und Diabetes mellitus
  449. Gravidität bei vorbestehendem Diabetes für die Leitlinien für die Praxis (AG Diabetes und Schwangerschaft der ÖDG)
  450. Gestationsdiabetes (GDM)
  451. Leitlinien Insulinpumpentherapie bei Kindern und Erwachsenen (Für den Ausschuss Insulinpumpentherapie der Österreichischen Diabetesgesellschaft)
  452. Antihyperglykämische Therapie bei Diabetes mellitus Typ 2
  453. Diabetische Nephropathie – Update 2012
  454. Retinal white blood cell flux and systemic blood pressure in patients with type 1 diabetes
  455. Progression to Type 2 Diabetes in Women with Former Gestational Diabetes: Time Trajectories of Metabolic Parameters
  456. Sex-specific differences in long-term glycemic control and cardiometabolic parameters in patients with type 1 diabetes treated at a tertiary care centre
  457. A two-step screening algorithm including fasting plasma glucose measurement and a risk estimation model is an accurate strategy for detecting gestational diabetes mellitus
  458. Obesity and Diabetes
  459. Adrenal Disorders
  460. Thyroid Disorders
  461. Challenges of Work–Life Balance for Women Physicians/Mothers Working in Leadership Positions
  462. CTX (Crosslaps) Rather than Osteopontin Is Associated with Disturbed Glucose Metabolism in Gestational Diabetes
  463. Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus
  464. Circulating progranulin levels in women with gestational diabetes mellitus and healthy controls during and after pregnancy
  465. Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review
  466. Associations of Body Mass Index (Maternal BMI) and Gestational Diabetes Mellitus with Neonatal and Maternal Pregnancy Outcomes in a Multicentre European Database (Diabetes and Pregnancy Vitamin D and Lifestyle Intervention for Gestational Diabetes Mel...
  467. Diabetic Polyneuropathy Relates to Bone Metabolism and Markers of Bone Turnover in Elderly Patients With Type 2 Diabetes: Greater Effects in Male Patients
  468. Women show a closer association between educational level and hypertension or diabetes mellitus than males: a secondary analysis from the Austrian HIS
  469. Evaluation of educational needs in patients with diabetes mellitus in respect of medication use in Austria
  470. Transcription factor 7-like 2 gene polymorphisms and gestational diabetes mellitus
  471. Levels of fetuin-A relate to the levels of bone turnover biomarkers in male and female patients with type 2 diabetes
  472. Comparison of HbA1c and oral glucose tolerance test for diagnosis of diabetes in patients with coronary artery disease
  473. Estimation of prehepatic insulin secretion: comparison between standardized C-peptide and insulin kinetic models
  474. Fatty Liver Index Predicts Further Metabolic Deteriorations in Women with Previous Gestational Diabetes
  475. Non-esterified fatty acid dynamics during oral glucose tolerance test in women with former gestational diabetes
  476. Influence of Increasing BMI on Insulin Sensitivity and Secretion in Normotolerant Men and Women of a Wide Age Span
  477. Characterization of Former Gestational Diabetes Mellitus: Prognostic, Therapeutic, and Predictive Aspects
  478. The Impact of Type 2 Diabetes on Circulating Adipokines in Patients with Metabolic Syndrome
  479. Fetuin-A Characteristics during and after Pregnancy: Result from a Case Control Pilot Study
  480. Incretin Effect in Women with Former Gestational Diabetes within a Short Period after Delivery
  481. Gestational Diabetes Prediction Score (GPS): Eine kosteneffektive Möglichkeit zur Vorhersage von Gestationsdiabetes bei Schwangerschaften mit normalem Nüchternblutzucker
  482. Sex and Gender Differences in Endocrinology
  483. Diabetes und Schwangerschaft
  484. Impact of diabetes mellitus and gender on exercise-related antiangiogenic endostatin/collagen XVIII release
  485. Influence of age, smoking and T2 diabetes on exercise related antiangiogenic endostatin/collagen XVIII release in men
  486. Diabetes und Schwangerschaft
  487. Gestationsdiabetes mellitus (GDM)
  488. Gestationsdiabetes mellitus (GDM) - Diagnostik, Therapie u. Nachsorge
  489. Admission Proinsulin Is Associated with Mortality in Patients with Admission Hyperglycemia during Acute Coronary Syndrome: Results from a Pilot Observational Study
  490. Skeletal Muscle Phosphodiester Content Relates to Body Mass and Glycemic Control
  491. Early Possible Risk Factors for Overt Diabetes After Gestational Diabetes Mellitus
  492. Recruitment of patients with type 2 diabetes for target group specific exercise programs at an Outpatient Department of a Medical University: A factor analysis
  493. Glucose Absorption in Gestational Diabetes Mellitus During an Oral Glucose Tolerance Test
  494. Insulin resistance is not associated with myocardial steatosis in women
  495. Relations of Adiponectin to Levels of Metabolic Parameters and Sexual Hormones in Elderly Type 2 Diabetic Patients
  496. Clinical characteristics, modalities and complications of diabetic patients with migration background at a Central European University Clinic
  497. Editorial: Sex- and gender-based medicine: a challenging field of research
  498. Health behaviour and attitude towards screening examinations in an Austrian urban and rural population: gender aspects – screening and sex
  499. Identification of a model of non-esterified fatty acids dynamics through genetic algorithms: The case of women with a history of gestational diabetes
  500. Perspectives on gender-specific medicine, course and learning style preferences in medical education: a study among students at the Medical University of Vienna
  501. Mechanism and Effects of Glucose Absorption during an Oral Glucose Tolerance Test Among Females and Males
  502. Risk Factor Profile and Pregnancy Outcome in Women with Type 1 and Type 2 Diabetes Mellitus
  503. Coverage of recommended vaccinations in subjects with diabetes mellitus and ischemic heart disease: results for women and men
  504. Shape of glucose, insulin, C-peptide curves during a 3-h oral glucose tolerance test: any relationship with the degree of glucose tolerance?
  505. Diabetes mellitus und Schwangerschaft
  506. N-terminal-pro-brain natriuretic peptide is decreased in insulin dependent gestational diabetes mellitus: a prospective cohort trial
  507. Circulating angiopoietin-2 and soluble Tie-2 in type 2 diabetes mellitus: a cross-sectional study
  508. Plasma neuropeptide Y levels differ in distinct diabetic conditions
  509. Sex-Specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus
  510. Sex-specific differences in glycemic control and cardiovascular risk factors in older patients with insulin-treated type 2 diabetes mellitus
  511. Body and Liver Fat Mass Rather Than Muscle Mitochondrial Function Determine Glucose Metabolism in Women With a History of Gestational Diabetes Mellitus
  512. Diabetes und Schwangerschaft
  513. Retinal Blood Flow in Type 1 Diabetic Patients With No or Mild Diabetic Retinopathy During Euglycemic Clamp
  514. Changes in Serum Lipid Levels During Pregnancy in Type 1 and Type 2 Diabetic Subjects
  515. Cross-sectional survey on thyroideal and gonadal hormones in adult patients with high-grade gliomas.
  516. Acht-wöchiges Bewegungsprogramm für Diabetiker verändert nachhaltig deren körperliche Aktivität
  517. Herzfunktion und myocardialer Lipidgehalt bei Frauen nach Gestationsdiabetes
  518. Science & gender: vision and mission
  519. Retinol-Binding Protein 4 in Patients with Gestational Diabetes Mellitus
  520. International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy
  521. Antithrombotic therapy in patients with coronary artery disease and with type 2 diabetes mellitus
  522. A Markov chain probability model of glucose tolerance in post gestational diabetes follow up study
  523. A Self-organizing map based morphological analysis of oral glucose tolerance test curves in women with gestational diabetes mellitus
  524. Diabetes mellitus – Leitlinien für die Praxis
  525. Osteocalcin Is Related to Enhanced Insulin Secretion in Gestational Diabetes Mellitus
  526. Metabolic diseases and associated complications: sex and gender matter!
  527. Serum Vaspin Concentrations in Relation to Insulin Sensitivity Following RYGB-Induced Weight Loss
  528. TCF7L2– Polymorphismen und Gestationsdiabetes
  529. Faktorenanalyse bei Patienten mit Diabetes mellitus, die den Teilnahmewunsch an einem medizinischen Trainingsprogramm beeinflussen
  530. Veränderungen der körperlichen Aktivität im 6 Monate Follow-up in Folge eines 8-wöchigen Bewegungsprogramms
  531. Effects of T4 replacement therapy on glucose metabolism in subjects with subclinical (SH) and overt hypothyroidism (OH)
  532. Value of the intravenous and oral glucose tolerance tests for detecting subtle impairments in insulin sensitivity and beta-cell function in former gestational diabetes
  533. Plasma Osteopontin Increases After Bariatric Surgery and Correlates with Markers of Bone Turnover But Not with Insulin Resistance
  534. Relationships between insulin secretion after intravenous and oral glucose administration in subjects with glucose tolerance ranging from normal to overt diabetes
  535. The Impact of Risk Factors and More Stringent Diagnostic Criteria of Gestational Diabetes on Outcomes in Central European Women
  536. Retinol – bindendes Protein 4 bei Patientinnen mit Gestationsdiabetes
  537. Diabetes und Schwangerschaft
  538. Insulin resistance has no impact on ghrelin suppression in pregnancy
  539. Impaired vascular nitric oxide bioactivity in women with previous gestational diabetes
  540. Diabetes mellitus – Leitlinien für die Praxis
  541. Diabetes und Schwangerschaft
  542. Visfatin Response to Glucose Is Reduced in Women With Gestational Diabetes Mellitus
  543. Elevated concentrations of asymmetric dimethylarginine are associated with deterioration of glucose tolerance in women with previous gestational diabetes mellitus
  544. Improved usability of the minimal model of insulin sensitivity based on an automated approach and genetic algorithms for parameter estimation
  545. Impaired cardiac autonomic function in women with prior gestational diabetes mellitus
  546. Insulin sensitivity during oral glucose tolerance test and its relations to parameters of glucose metabolism and endothelial function in type 2 diabetic subjects under metformin and thiazolidinedione
  547. Insulinogenic indices from insulin and C-peptide: Comparison of beta-cell function from OGTT and IVGTT
  548. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes
  549. Impaired beta-cell function in lean normotolerant former gestational diabetic women
  550. Gestational diabetes mellitus is associated with increased C-reactive protein concentrations in the third but not second trimester
  551. Sind "Designer"-Insuline die "besseren" Insuline?
  552. Severe diabetic fetopathy despite strict metabolic control
  553. Large-for-gestational-age newborns in women with insulin-treated gestational diabetes under strict metabolic control
  554. Endocrine Changes in Diabetic Pregnancy
  555. Fetal Hyperinsulinism and Maternal One-Hour Postload Plasma Glucose Level
  556. Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus
  557. Haptoglobin Phenotype and Gestational Diabetes
  558. 40th EASD Annual Meeting of the European Association for the Study of Diabetes
  559. Diabetes in der Schwangerschaft
  560. Diabetes in der Praxis
  561. Gestational Diabetes
  562. Mode of action of ipomoea batatas (caiapo) in type 2 diabetic patients
  563. Basal and dynamic proinsulin-insulin relationship to assess β-cell function during OGTT in metabolic disorders
  564. Diabetes-Screening in der Schwangerschaft
  565. Increased Intramyocellular Lipid Concentration Identifies Impaired Glucose Metabolism in Women With Previous Gestational Diabetes
  566. Circulating concentrations of asymmetrical dimethyl- L -arginine are increased in women with previous gestational diabetes
  567. Ocular hyperperfusion following onset of intensified insulin therapy is inversely correlated with plasma endothelin-1 in Type I diabetes
  568. Book reviews
  569. Increased plasma leptin in gestational diabetes
  570. The increased insulin sensitivity in growth hormone-deficient adults is reduced by growth hormone replacement therapy
  571. Dexamethasone lowers circulating E-selectin and ICAM-1 in healthy men
  572. 35th Annual Meeting of the European Association for the Study of Diabetes
  573. Elevation of plasma leptin concentrations in obese hyperinsulinaemic hypothyroidism before and after treatment
  574. Ectopic thyroid gland simulating a submandibular tumor
  575. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease
  576. Persistent Elevation and Metabolic Dependence of Circulating E-Selectin after Delivery in Women with Gestational Diabetes Mellitus
  577. Persistent Elevation and Metabolic Dependence of Circulating E-Selectin after Delivery in Women with Gestational Diabetes Mellitus
  578. Pronounced Insulin Resistance and Inadequate  -cell Secretion Characterize Lean Gestational Diabetes During and After Pregnancy
  579. Amylin: History and Overview
  580. Amylin Release During Oral Glucose Tolerance Test
  581. Elevated Islet Amyloid Pancreatic Polypeptide and Proinsulin in Lean Gestational Diabetes
  582. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes
  583. β-cell activity and hepatic insulin extraction following dexamethasone administration in healthy subjects
  584. Integrated mathematical model to assess beta-cell activity during the oral glucose test
  585. Intravenous calcitriol normalizes insulin sensitivity in uremic patients
  586. Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term study
  587. Increased levels of circulating islet amyloid polypeptide in patients with chronic renal failure have no effect on insulin secretion.
  588. Role of islet amyloid polypeptide secretion in insulin-resistant humans
  589. Long-term treatment with nifedipine reduces urinary albumin excretion and glomerular filtration rate in normotensive type 1 diabetic patients with microalbuminuria
  590. Hormonal and blood glucose responsiveness as an indicator of specific emotional arousal in type 1 diabetics
  591. Elevated hepatic insulin extraction in essential hypertension
  592. Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans
  593. Colour doppler imaging of partial subclavian steal syndrome
  594. β-Cell hypersecretion and not reduced hepatic insulin extraction is the main cause of hyperinsulinemia in obese nondiabetic subjects
  595. Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery
  596. Laboratory monitoring of thromboprophylaxis with low molecular weight and standard heparin
  597. Insulin Sensitivity, Secretion and Hepatic Extraction in Untreated Hypertensive Patients